NBA, NHL, MLS, ATP among those queried

WASHINGTON -- Congressmen looking into steroids in sports
sent letters Tuesday to the heads of the NBA, NHL and five other
groups asking for information about their drug-testing policies.

The House Government Reform Committee sent a similar request to the NFL last week.

"This is the compare-and-contrast phase of the investigation," said David Marin, spokesman for committee chairman Tom Davis, a Virginia Republican.

During the panel's 11-hour hearing on steroids in baseball last month -- with Mark McGwire, Jose Canseco and commissioner Bud Selig among the witnesses -- several lawmakers threatened federal legislation to govern drug testing in baseball and possibly all U.S. sports.

The seven letters sent Tuesday were addressed to NBA
commissioner David Stern, NHL commissioner Gary Bettman, ATP CEO
Mark Miles, Major League Soccer commissioner Don Garber, U.S.
Soccer Federation president Bob Contiguglia, USA Track & Field CEO
Craig Masback and USA Cycling CEO Gerard Bisceglia.

"As the committee has stated publicly numerous times, its focus
on the issue of performance-enhancing drug use in sports is not
limited to professional baseball," Davis and the panel's ranking
Democrat, Henry Waxman of California, said in the letter.

"The hearing was the first in a series for the committee as
part of its ongoing investigation into steroid policies for
professional and amateur sports."

"These are probably not the last letters," said Waxman
spokeswoman Karen Lightfoot, who added that the NCAA should receive
a similar request soon.

The officials were given an April 12 deadline for turning over
copies of their sports' current and past drug-testing policies and
information about how those were negotiated.

The committee also asked for information such as the number of
drug tests each year, the number of positive results and which
substances are tested for. The letters specified that the committee
wants "summary information, and does not require identification of
individual players."

"A majority of this stuff is already up on our Web site, and
anything that's not we'll be more than happy to supply them," ATP
spokesman David Higdon said. "The deadline's a little tight, but
we'll do all we can."

USA Track & Field confirmed that it received a letter from Davis
and Waxman, requesting basic details of USATF's anti-doping
policies and drug testing.

"We welcome the opportunity to provide this information to the
Committee, and we will provide them with all information we have
available, which dates back to the 1980s, in order to fulfill their
request," Masback said in a USATF statement.

USATF, and all other U.S. Olympic sports, turned drug testing
and punishment over to the U.S. Anti-Doping Agency in 2000. USATF,
often accused in the past of overlooking or hiding drug offenses,
has recommended that first-time offenders receive a lifetime ban.
Track athletes can be suspended based on evidence even if they have
not tested positive. Two such cases, for world 100-meter record
holder Tim Montgomery and sprinter Chryste Gaines, will be heard
this summer by the international Court of Arbitration for Sport.

The NHL does not test players for performance-enhancing drugs,
while first-time offenders are suspended for five games in the NBA.
Tennis, cycling and track and field follow International Olympic
Committee and World Anti-Doping Agency standards, including a
minimum two-year ban for a first offense and a lifetime ban for a
second offense.

"We're so far ahead of baseball we're unconcerned," Higdon said.

Drug testing for USSF is covered by FIFA, soccer's governing body, and the U.S. Olympic Committee.

The committee's letter to sports bodies

    On March 17, 2005, the Committee on Government Reform held a hearing on Major League Baseball and its current drug testing policy. As the committee has stated publicly numerous times, its focus on the issue of performance-enhancing drug use in sports is not limited to professional baseball. The hearing was the first in a series for the committee as part of its ongoing investigation into steroid policies for professional and amateur sports.

    As part of this investigation, we are requesting basic information on steroid policies and steroid testing from a number of sports leagues. As such, we ask that (appropriate league named) provide the committee with the following information:

    1. A complete copy of the current drug testing policy, as well as each drug testing policy that has been in place since (appropriate league name) began testing for performance-enhancing drugs. The documents provided should include, but not be limited to:

    a. details of the testing protocol;
    b. how the testing is conducted;
    c. the notice provided to players prior to testing;
    d. how random testing is conducted;
    e. protocol for offseason;
    f. protocol for players residing outside of the United States during the offseason, if applicable; and
    g. the protocol for disclosing the identity of players who test positive.

    2. For each drug policy provided under No. 1, provide the specifics as to how the policies were formulated and negotiated between (appropriate league name) and other entities.

    3. Annual summary information on all performance-enhancing drug test results since the (appropriate league name) began testing for such drugs. The Committee is requesting summary information, and does not require identification of individual players. This request includes, but is not limited to:

    a. the number of tests conducted each year;
    b. the number of players tested each year;
    c. the specific substances tested;
    d. the number of positive test results;
    e. the number of positive tests for each specific drug.

    We request that the (appropriate league named) hand-deliver two copies of this information by 6:00 p.m. on April 12, 2005. One copy is to be delivered to the majority staff at room 2157 in the Rayburn House Office Building, and one copy is to be delivered to the minority staff at room B-350A in the Rayburn House Office Building.

    Tom Davis, chairman
    Henry A. Waxman, ranking minority member